Birgitta Schweickert

Dr. Birgitta Schweickert

Epidemiology of infectious diseases, Robert Koch Institute, Berlin, Germany

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2013 in Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Verified
Journal Article
Closed access
PDF file
BSBirgitta Schweickert
Birgitta Schweickert
WKW.V. Kern
W.V. Kern
KWK. de With
K. de With
EME. Meyer
E. Meyer
RBR. Berner
R. Berner
TET. Eckmanns
T. Eckmanns

1 June 2011 in Clinical Microbiology and Infection
Verified
Journal Article
Open access
PDF file
BSBirgitta Schweickert
Birgitta Schweickert
CGC. Geffers
C. Geffers
TFTracey Farragher
Tracey Farragher
PGP. Gastmeier
P. Gastmeier
MBM. Behnke
M. Behnke
FSF. Schwab
F. Schwab
Nosocomial infections with methicillin-resistant Staphylococcus aureus (MRSA) account for increased morbidity, mortality and healthcare costs in critically ill patients worldwide. The intensive care unit (ICU) component of the German surveillance system for nosocomial infections (Krankenhaus-Infektions-Surveillance-System, KISS) has been supplemented with a module targeting the surveillance of multiresistant pathogens [Multiresistente Erreger (MRE)-KISS] in order to account for the increasing burden of antibiotic-resistant bacteria. The aim of this study was to assess the association between structural and organizational characteristics of ICUs and the number of nosocomial MRSA cases. Data were derived from routine data collected in the frame of the national surveillance system of nosocomial infections (ICU- and MRE-KISS) from January 2007 to December 2008 and from a questionnaire inquiring about structure and process parameters. One hundred and forty ICUs performing active screening have been included. Process parameters such as isolation of MRSA patients, decolonization procedures and introduction of MRSA alert systems have been implemented by the majority of the ICUs, whereas the application mode of screening procedures and pre-emptive isolation measures is heterogeneous. Multivariable analysis using negative binominal regression models shows that a stay on a medical ICU has a protective effect (incidence rate ratio, 0.42; 95% confidence interval, 0.24-0.74; p = 0.003), whereas the imported MRSA incidence is significantly associated with the number of nosocomial MRSA cases (incidence rate ratio, 1.74; 95% confidence interval, 1.23-2.45; p = 0.002). Structure and process parameters do not show any effect. ICU type and imported MRSA incidence should be considered for benchmarking between hospitals.

31 December 2011 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
BSBirgitta Schweickert
Birgitta Schweickert
INI. Noll
I. Noll
MFM. Feig
M. Feig
HCH. Claus
H. Claus
GKG. Krause
G. Krause
TET. Eckmanns
T. Eckmanns

22 March 2014 in Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Verified
Journal Article
Closed access
PDF file
BSBirgitta Schweickert
Birgitta Schweickert
TET. Eckmanns
T. Eckmanns
SBS. Bärwolff
S. Bärwolff
NWN. Wischnewski
N. Wischnewski
EME. Meyer
E. Meyer

18 March 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
BSBirgitta Schweickert
Birgitta Schweickert
NWNiklas Willrich
Niklas Willrich
MFMarcel Feig
Marcel Feig
MSMarc Schneider
Marc Schneider
MBMichael Behnke
Michael Behnke
MSMuna Abu Sin
Muna Abu Sin
Background: Antimicrobial consumption (AMC) patterns, besides prescribing behaviors, reflect the changing epidemiology of infectious diseases. Routine surveillance data have been used to investigate the development of AMC from 2017 to 2023 and the impact of COVID-19 within the context of the framing time periods. Methods: Data from 112 hospitals, continuously participating from 2017 to 2023 in the national surveillance system of hospital antimicrobial consumption based at the Robert Koch Institute, were analyzed according to the WHO ATC (Anatomical Therapeutic Chemical)/DDD (Defined Daily Dose) method and categorized according to the WHO AWaRe-classification. AMC was quantified by consumption density (CD) expressed in DDD/100 patient days (PD) and DDD/100 admissions (AD). The time period was subdivided into three phases: pre-pandemic phase (2017–2019), main pandemic phase (2020–2021) and transition phase (2022–2023). Linear regression models have been used to determine the presence of an overall trend, the change in intra-phasic trends and phase-specific mean consumption levels over time. Results: From 2017 to 2023 total antibiotic consumption decreased by 7% from 57.1 to 52.9 DDD/100 PD. Four main kinetic patterns emerged across different antibiotic classes: Pattern 1 displays a decreasing pre-pandemic trend, which slowed down throughout the pandemic and transition phase and was exhibited by second-generation cephalosporins and fluoroquinolones. Pattern 2 reveals a rising pre-pandemic trend, which decelerated in the pandemic phase and accelerated again in the transition phase and was expressed by aminopenicillins/beta-lactamase inhibitors, beta-lactamase sensitive pencillins, azithromycin and first-generation cephalosporins. Pattern 3 shows elevated mean consumption levels in the pandemic phase exhibited by carbapenems, glycopeptides, linezolid and third-generation cephalosporins. Pattern 4 reveals a rising trend throughout the pre-pandemic and pandemic phase, which reversed in the transition phase without achieving pre-pandemic levels and was expressed by beta-lactamase resistant penicillins, daptomycin, fosfomycin (parenteral) and ceftazidime/avibactam. Conclusions: Kinetic consumption patterns across different antibiotic classes might reflect COVID-19-related effects and associated changes in the epidemiology of co-circulating pathogens and health care supply. Broad-spectrum antibiotics with persisting elevated consumption levels throughout the transition phase require special attention and focused antimicrobial stewardship activities.

19 September 2023
Verified
Book Chapter
Open access
PDF file
DSDunja Said
Dunja Said
MSMuna Abu Sin
Muna Abu Sin
AZArina Zanuzdana
Arina Zanuzdana
BSBirgitta Schweickert
Birgitta Schweickert
TETim Eckmanns
Tim Eckmanns
Zusammenfassung: Die Steigerung der Lebenserwartung und der damit wachsende Anteil an Personen hohen Alters hat in den letzten Jahren in Deutschland zu einem zunehmenden Anteil an pflegebedürftigen Menschen geführt (Statistisches Bundesamt 2022). Nach Angaben des Statistischen Bundesamtes beträgt die Anzahl der Pflegebedürftigen derzeit ca. 4,1 Mio, wobei mit rund 80 % der überwiegende Anteil zu Hause, entweder durch Angehörige (51,3 %) oder ambulante Pflege- und Betreuungsdienste (23,8 %) bzw. eine Kombination von beidem, versorgt wird, während die anderen 20 % vollstationär in einem der 15.000 Alten- und Pflegeheime untergebracht sind (Statistisches Bundesamt 2020, 2022).Insbesondere die Bewohnenden dieser Einrichtungen gehören zu den Hochrisikogruppen für einen schweren oder tödlichen Verlauf von Infektionskrankheiten wie Covid-19. Der Vulnerabilität liegen verschiedene Faktoren zugrunde, wie Gebrechlichkeit und Immunschwäche sowie Komorbiditäten, insbesondere Herz-Kreislauf-Erkrankungen, Diabetes oder Demenz. In Altenheimen leben darüber hinaus auch besonders häufig hochaltrige Personen ab 80 Jahren, die z. B. in Kombination mit einer Demenzerkrankung zwei wesentliche Risikofaktoren für einen tödlichen Covid-19-Verlauf vereinen (España et al. 2021).